# MACROH2A2

## Overview
The MACROH2A2 gene encodes the macroH2A.2 histone variant, a specialized protein involved in chromatin organization and gene regulation. As a histone variant, macroH2A.2 plays a crucial role in maintaining chromatin structure by stabilizing DNA at the nucleosome entry/exit site, thereby influencing chromatin compaction and limiting relaxation, particularly in response to DNA damage (Kozlowski2018MacroH2A). This protein is characterized by a tripartite structure, including a histone fold, a linker region, and a macrodomain, which contribute to its function in chromatin architecture and transcriptional repression (Kozlowski2018MacroH2A). The MACROH2A2 gene is notably expressed in the brain and during embryonic development, suggesting its involvement in neuronal plasticity and brain development (Kozlowski2018MacroH2A). Additionally, macroH2A.2 is implicated in various cellular processes, including maintaining pluripotency in embryonic stem cells and acting as a barrier to somatic cell reprogramming, highlighting its significance in cellular identity and differentiation (Yildirim2014A).

## Structure
The MACROH2A2 protein is a histone variant characterized by a tripartite structure consisting of a histone fold, a linker region, and a macrodomain. The linker region is a 39-amino acid long, basic, and intrinsically disordered segment that resembles the C-terminal tail of linker histone H1. This region plays a crucial role in stabilizing chromatin architecture by reducing chromatin relaxation and maintaining heterochromatin structure (Kozlowski2018MacroH2A). The macrodomain of MACROH2A2, while not necessary for the primary functions of the linker, may contribute to heterochromatin stability through protein-protein interactions (Kozlowski2018MacroH2A).

Structurally, MACROH2A2 has a conserved macrodomain fold similar to macroH2A1.1, but with significant differences in the shape and chemical properties of its major surface pocket. Notably, two prolines (Pro 313 and Pro 315) in MACROH2A2 distort the phosphate-binding loop, making it incompatible with nucleotide binding, unlike macroH2A1.1, which can bind ADP-ribose (Kozlowski2018MacroH2A). This structural divergence suggests a unique role for MACROH2A2, potentially in brain development or neuronal plasticity, as it is highly expressed in adult brain tissue and during embryonic development in the central nervous system (Kozlowski2018MacroH2A).

## Function
The MACROH2A2 gene encodes the macroH2A.2 histone variant, which plays a significant role in chromatin structure and gene regulation in healthy human cells. MacroH2A.2 is involved in maintaining chromatin plasticity and nuclear organization by stabilizing DNA at the nucleosome entry/exit site, thereby enhancing chromatin compaction and limiting chromatin relaxation, particularly upon DNA damage (Kozlowski2018MacroH2A). This histone variant is also associated with transcriptional repression, particularly in heterochromatic regions, and is enriched in regions marked by repressive histone modifications such as H3K27me3 (Sun2019Histone).

In embryonic stem cells, macroH2A.2 exhibits dynamic behavior, being rapidly replaced at promoters of highly transcribed genes, which suggests a role in regulating gene expression and maintaining pluripotency (Yildirim2014A). Upon differentiation, macroH2A.2 becomes more stably incorporated into chromatin, particularly in gene-poor regions, indicating its role in stabilizing the epigenetic state of differentiated cells (Yildirim2014A). Additionally, macroH2A.2 acts as a barrier to somatic cell reprogramming, suggesting its involvement in maintaining cellular identity (Mohammed2023MacroH2A).

## Clinical Significance
Alterations in the expression of the MACROH2A2 gene have significant clinical implications, particularly in the context of cancer. In glioblastoma (GBM), low expression of MACROH2A2 is associated with increased tumor cell self-renewal and poorer prognosis. This gene acts as a tumor suppressor by repressing genes linked to stemness and self-renewal, and its reduced expression leads to more aggressive tumor behavior and shorter survival in patients (Nikolic2023macroH2A2). High levels of MACROH2A2 are correlated with better survival outcomes, especially in IDH-wildtype GBM patients (Nikolic2023macroH2A2).

In anal neoplasms, high expression of MACROH2A2 is linked to low-grade tumors and delayed recurrence, while its loss in HPV-positive anal squamous cell carcinoma promotes tumorigenesis (Lai2024Roles). The gene's expression also plays a role in colorectal cancer, where its downregulation is associated with increased radioresistance, suggesting its involvement in the DNA damage response (Na2019Deficiency).

These findings highlight the potential of MACROH2A2 as a prognostic marker and therapeutic target in various cancers, given its role in modulating epigenetic programs and influencing tumor cell behavior (Nikolic2023macroH2A2).


## References


[1. (Lai2024Roles) Po Man Lai and Kui Ming Chan. Roles of histone h2a variants in cancer development, prognosis, and treatment. International Journal of Molecular Sciences, 25(6):3144, March 2024. URL: http://dx.doi.org/10.3390/ijms25063144, doi:10.3390/ijms25063144. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25063144)

[2. (Mohammed2023MacroH2A) Wazim Mohammed Ismail, Amelia Mazzone, Flavia G. Ghiraldini, Jagneet Kaur, Manvir Bains, Amik Munankarmy, Monique S. Bagwell, Stephanie L. Safgren, John Moore-Weiss, Marina Buciuc, Lynzie Shimp, Kelsey A. Leach, Luis F. Duarte, Chandandeep S. Nagi, Saul Carcamo, Chi-Yeh Chung, Dan Hasson, Neda Dadgar, Jian Zhong, Jeong-Heon Lee, Fergus J. Couch, Alexander Revzin, Tamas Ordog, Emily Bernstein, and Alexandre Gaspar-Maia. Macroh2a histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming. Communications Biology, February 2023. URL: http://dx.doi.org/10.1038/s42003-023-04571-1, doi:10.1038/s42003-023-04571-1. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-023-04571-1)

[3. (Yildirim2014A) Ozlem Yildirim, Jui-Hung Hung, Ryan J. Cedeno, Zhiping Weng, Christopher J. Lengner, and Oliver J. Rando. A system for genome-wide histone variant dynamics in es cells reveals dynamic macroh2a2 replacement at promoters. PLoS Genetics, 10(8):e1004515, August 2014. URL: http://dx.doi.org/10.1371/journal.pgen.1004515, doi:10.1371/journal.pgen.1004515. This article has 29 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1004515)

[4. (Kozlowski2018MacroH2A) Marek Kozlowski, David Corujo, Michael Hothorn, Iva Guberovic, Imke K Mandemaker, Charlotte Blessing, Judith Sporn, Arturo Gutierrez‐Triana, Rebecca Smith, Thomas Portmann, Mathias Treier, Klaus Scheffzek, Sebastien Huet, Gyula Timinszky, Marcus Buschbeck, and Andreas G Ladurner. Macroh2a histone variants limit chromatin plasticity through two distinct mechanisms. EMBO reports, September 2018. URL: http://dx.doi.org/10.15252/embr.201744445, doi:10.15252/embr.201744445. This article has 65 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.15252/embr.201744445)

[5. (Sun2019Histone) Zhen Sun and Emily Bernstein. Histone variant macroh2a: from chromatin deposition to molecular function. Essays in Biochemistry, 63(1):59–74, April 2019. URL: http://dx.doi.org/10.1042/ebc20180062, doi:10.1042/ebc20180062. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/ebc20180062)

[6. (Na2019Deficiency) Yoo Jin Na, Bo Ram Kim, Jung Lim Kim, Sanghee Kang, Yoon A. Jeong, Seong Hye Park, Min Jee Jo, Jeong-Yub Kim, Hong Jun Kim, Sang Cheul Oh, and Dae-Hee Lee. Deficiency of 15-lox-1 induces radioresistance through downregulation of macroh2a2 in colorectal cancer. Cancers, 11(11):1776, November 2019. URL: http://dx.doi.org/10.3390/cancers11111776, doi:10.3390/cancers11111776. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers11111776)

[7. (Nikolic2023macroH2A2) Ana Nikolic, Francesca Maule, Anna Bobyn, Katrina Ellestad, Seungil Paik, Sajid A. Marhon, Parinaz Mehdipour, Xueqing Lun, Huey-Miin Chen, Claire Mallard, Alexander J. Hay, Michael J. Johnston, Christopher J. Gafuik, Franz J. Zemp, Yaoqing Shen, Nicoletta Ninkovic, Katalin Osz, Elodie Labit, N. Daniel Berger, Duncan K. Brownsey, John J. Kelly, Jeff Biernaskie, Peter B. Dirks, Darren J. Derksen, Steven J. M. Jones, Donna L. Senger, Jennifer A. Chan, Douglas J. Mahoney, Daniel D. De Carvalho, and Marco Gallo. Macroh2a2 antagonizes epigenetic programs of stemness in glioblastoma. Nature Communications, May 2023. URL: http://dx.doi.org/10.1038/s41467-023-38919-2, doi:10.1038/s41467-023-38919-2. This article has 5 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-023-38919-2)